Skip to menu
Skip to content
Skip to footer
Menu
Study
Research
Partners and community
About
Search
Frazer Institute
Home
About
About
News
Our people
History
Our supporters
The Translational Research Institute
Research
Research
Research themes
Research centres
Research by disease
Facilities and support services
Innovation and commercial development
Study
Study
Undergraduate
Honours
Higher Degree by Research
Scholarships
Visiting Research Students
Why should I do my research project at Frazer Institute?
Laboratory to patient
Laboratory to patient
Clinical trials
Clinical research facilities
Community and alumni
Donate now
Contact
Study
Research
Partners and community
About
UQ home
News
Events
Give
Contact
Search term
UQ home
News
Events
Give
Contact
Frazer Institute
Menu
Home
About
Show About sub-navigation
News
Our people
History
Our supporters
The Translational Research Institute
Research
Show Research sub-navigation
Research themes
Research centres
Research by disease
Facilities and support services
Innovation and commercial development
Study
Show Study sub-navigation
Undergraduate
Honours
Higher Degree by Research
Scholarships
Visiting Research Students
Why should I do my research project at Frazer Institute?
Laboratory to patient
Show Laboratory to patient sub-navigation
Clinical trials
Clinical research facilities
Community and alumni
Donate now
Contact
Miss Jeniffer Loaiza Naranjo
Research Officer
Frazer Institute
j.loaizanaranjo@uq.edu.au
Publications
Journal Articles
(2)
Journal Articles
Buckle, Irina
,
Loaiza Naranjo, Jeniffer D.
,
Bergot, Anne-Sophie
,
Zhang, Vivian
,
Talekar, Meghna
,
Steptoe, Raymond J.
,
Thomas, Ranjeny
and
Hamilton-Williams, Emma E.
(
2022
).
Tolerance induction by liposomes targeting a single CD8 epitope IGRP in a model of type 1 diabetes is impeded by co-targeting a CD4 islet epitope
.
Immunology and Cell Biology
,
100
(
1
),
33
-
48
. doi:
10.1111/imcb.12506
Loaiza Naranjo, Jeniffer D.
,
Bergot, Anne-Sophie
,
Buckle, Irina
and
Hamilton-Williams, Emma E.
(
2020
).
A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes
.
Current Diabetes Reports
,
20
(
12
)
70
,
70
. doi:
10.1007/s11892-020-01363-3
